Navigation Links
Testosterone Treatment Lawsuit News: Federal Court OverseeingTestosterone Litigation Convenes Conference to Discuss Pretrial Management, Bernstein Liebhard LLP Reports
Date:8/25/2014

New York, New York (PRWEB) August 25, 2014

Testosterone treatment lawsuits (http://www.injurybeacon.com/testosterone-androgel/) continue to move forward in a multidistrict litigation now underway in U.S. District Court, Northern District of Illinois, Bernstein Liebhard LLP reports. According to court documents, the litigation’s first case management conference was convened on August 22nd, at which time discovery and other pretrial management issues where addressed. The parties also discussed ways in which the federal proceeding could coordinate with state litigations involving similar testosterone lawsuits. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“Our Firm has heard from a number of men who suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other cardiovascular injuries, allegedly due to their use of prescription low testosterone therapies. We are pleased to see these cases are moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now evaluating testosterone lawsuits on behalf of men who were allegedly harmed by these medications.

Testosterone Treatment Allegations
Court documents indicate that at least 177 testosterone treatment lawsuits have been filed in the Northern District of Illinois against the manufacturers of AndroGel, Androderm, Testim and other prescription medications indicated to treat men with low levels of the hormone. The defendants in these cases are all accused of concealing the cardiovascular risks associated with their products, and of failing to warn doctors and patients about their potential to cause serious heart problems.

According to court records, the litigation involving low testosterone therapy began to mount shortly after the U.S. Food & Drug Administration (FDA) announced that it was investigating the cardiovascular risks that may be linked to its use. In an alert issued on January 31, 2014, the agency said its review was prompted by two studies which indicated that older men, as well as those with pre-existing heart disease, were more likely to suffer heart attacks, strokes or death if they were using testosterone medications.

The FDA’s investigation of testosterone treatments is continuing. The agency is scheduled to convene an outside panel of advisors on September 17th to discuss the cardiovascular side effects potentially associated with the drugs, as well as ways to mitigate those risks.*

Alleged victims of heart attacks, strokes, deep vein thrombosis, pulmonary embolism, or other life-threatening cardiovascular events potentially associated with low testosterone therapy may be entitled to compensation for their injury-related damages. Learn more about filing a testosterone treatment lawsuit by visiting Bernstein Liebhard LLP’s website, or calling the Firm today at 800-511-5092.

*fda.gov/AdvisoryCommittees/Calendar/ucm404905.htm, FDA, July 17, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.injurybeacon.com
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/testosterone-lawsuit/testosterone-heart-attack/prweb12118557.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Testosterone Lawsuits Involving AndroGel, other Prescription Therapies Move Forward in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports
2. Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports.
3. Common Chemicals May Lower Testosterone Levels, Study Finds
4. Testosterone Lawsuit Alleges AndroDerm Patch Caused Death of Virginia Man, Bernstein Liebhard LLP Reports
5. Partner Kristine Kraft Appointed to the Plaintiffs’ Steering Committee (PSC) in Federal Testosterone Replacement Therapy MDL, Schlichter, Bogard & Denton, LLP Reports
6. Testosterone in healthy men increases their brains response to threat
7. FDA Seeks Answers As Testosterone Lawsuits Mount Against "Low T" Drug Makers
8. Testosterone Lawsuit News: Bernstein Liebhard LLP Notes Report Indicating That More Men are Seeking Prescription Supplements
9. Judge Kennelly Appoints Attorney Michelle Kranz to the Plaintiffs’ Executive Committee in the Testosterone Replacement Therapy MDL
10. Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone
11. Class Action Lawsuit in Canada Alleges Manufacturer of Delatestryl Testosterone Injection Failed to Warn of Cardiovascular Risks, Parker Waichman LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... videos a whole new perspective by using the title layers in ProSlice Levels ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Medical Market Analysis 2016 - Forecast to 2022" report ... The report contains up to date financial data derived from ... of major trends with potential impact on the market during ... market segmentation which comprises of sub markets, regional and country ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... June 23, 2016 , , ... July 7, 2016 , , , , LOCATION: , , ... , , , EXPERT PANELISTS:  , , , Frost & ... Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, ... The global pharmaceutical industry is witnessing an exceptional era. Several new ...
Breaking Medicine Technology: